Review



mouse vegf elisa kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    R&D Systems mouse vegf elisa kit
    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor <t>(VEGF)</t> mRNA and protein expression levels in different groups.
    Mouse Vegf Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 658 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pmc13108756-113-26-31?v=R%26D+Systems
    Average 96 stars, based on 658 article reviews
    mouse vegf elisa kit - by Bioz Stars, 2026-07
    96/100 stars

    Images

    1) Product Images from "Targeted transferosomal delivery of cetirizine: A new approach to alopecia management"

    Article Title: Targeted transferosomal delivery of cetirizine: A new approach to alopecia management

    Journal: PLOS One

    doi: 10.1371/journal.pone.0347648

    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) mRNA and protein expression levels in different groups.
    Figure Legend Snippet: Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) mRNA and protein expression levels in different groups.

    Techniques Used: Expressing



    Similar Products

    94
    Multi Sciences (Lianke) Biotech Co Ltd vegf
    Vegf, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pm41651824-374-19-31?v=Multi+Sciences+%28Lianke%29+Biotech+Co+Ltd
    Average 94 stars, based on 1 article reviews
    vegf - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    96
    R&D Systems mouse vegf elisa kit
    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor <t>(VEGF)</t> mRNA and protein expression levels in different groups.
    Mouse Vegf Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pmc13108756-113-26-31?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    mouse vegf elisa kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    93
    Boster Bio mouse vegf elisa kit picokine
    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor <t>(VEGF)</t> mRNA and protein expression levels in different groups.
    Mouse Vegf Elisa Kit Picokine, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/10__1007_slash_s12247___026___10551___9-110-9-14?v=Boster+Bio
    Average 93 stars, based on 1 article reviews
    mouse vegf elisa kit picokine - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    95
    R&D Systems mouse vegf duoset elisa kit
    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor <t>(VEGF)</t> mRNA and protein expression levels in different groups.
    Mouse Vegf Duoset Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pm41899867-152-1-7?v=R%26D+Systems
    Average 95 stars, based on 1 article reviews
    mouse vegf duoset elisa kit - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    96
    R&D Systems quantikine elisa
    TRIM enhances vascularity. ( A , B ) Representative images of TA cross-sections in WT and D2. mdx mice at 14 dpt. Laminin + immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. ( C ) Summary values ( n = 4–5/group) for area occupied by ECs were calculated as: total EC area/number (#) of fibers. ( D ) Summary values ( n = 4–5/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers. Summary values presented for 14 dpt. Angiogenic factors are increased with TRIM. ( E ) VEGF concentration in whole-muscle TA homogenates ( n = 5/group) probed for by <t>ELISA.</t> Summary values are means ± SEM; comparisons made vs. WT and vehicle controls by 2-Way ANOVA, p < 0.05 = significant. Scale bars = 100 μm.
    Quantikine Elisa, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pmc13028039-127-18-22?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    quantikine elisa - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    R&D Systems mouse vegf quantikine elisa kit
    TRIM enhances vascularity. ( A , B ) Representative images of TA cross-sections in WT and D2. mdx mice at 14 dpt. Laminin + immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. ( C ) Summary values ( n = 4–5/group) for area occupied by ECs were calculated as: total EC area/number (#) of fibers. ( D ) Summary values ( n = 4–5/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers. Summary values presented for 14 dpt. Angiogenic factors are increased with TRIM. ( E ) VEGF concentration in whole-muscle TA homogenates ( n = 5/group) probed for by <t>ELISA.</t> Summary values are means ± SEM; comparisons made vs. WT and vehicle controls by 2-Way ANOVA, p < 0.05 = significant. Scale bars = 100 μm.
    Mouse Vegf Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pm41820594-103-1-7?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    mouse vegf quantikine elisa kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    R&D Systems quantikine mouse vegf elisa kit
    Angiogenesis improvement after mLVRF systemic injections (A) Timeline of the injection protocol. Groups of 7- to 10-week-old male mdx mice were injected intravenously with a single dose AAV9 encoding the mLVRF isoform or an AAV9 scramble as control (3E+13 vg/kg) ( n = 4–5 mice per group). Four weeks after this pre-treatment, mice were injected intravenously with ASO (50 mg/kg/week) or PBS during 12 weeks. Age-matched C57BL/10 wild-type mice were used as controls (WT). One week after the last injection, tissues were collected as described in the section. (B) Quantification of the expression of mLVRF performed by qPCR on gastrocnemius (GAS) total RNA. (C) <t>VEGF</t> concentration measured by <t>ELISA</t> on GAS protein lysates (∗ p < 0.05; ∗∗∗∗ p < 0.0001, analyzed by one-way ANOVA). (D) CD31 expression quantified by qPCR on total RNA extracted from GAS muscles (∗ p < 0.05, ∗∗∗ p < 0.001; analyzed by one-way ANOVA). (E) CD31 immunostaining of TA muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bars, 50 μm. (F) Distribution of the proportion of fibers as a function of the number of associated blood vessels. (G) Quantification of the mean number of blood vessels per myofiber (∗ p < 0.05, ∗∗∗∗ p < 0.0001; analyzed by one-way ANOVA). (H and I) Proportion of fibers with no associated blood vessels (H) or associated with 5 vessels (I). (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Data regarding blood vessels were obtained from CD31 immunostaining. (J) Quantification of the VEGFR3 expression by qPCR on GAS RNA (∗∗ p < 0.01, analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).
    Quantikine Mouse Vegf Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pmc12860987-273-8-14?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    quantikine mouse vegf elisa kit - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    96
    R&D Systems vegf
    Angiogenesis improvement after mLVRF systemic injections (A) Timeline of the injection protocol. Groups of 7- to 10-week-old male mdx mice were injected intravenously with a single dose AAV9 encoding the mLVRF isoform or an AAV9 scramble as control (3E+13 vg/kg) ( n = 4–5 mice per group). Four weeks after this pre-treatment, mice were injected intravenously with ASO (50 mg/kg/week) or PBS during 12 weeks. Age-matched C57BL/10 wild-type mice were used as controls (WT). One week after the last injection, tissues were collected as described in the section. (B) Quantification of the expression of mLVRF performed by qPCR on gastrocnemius (GAS) total RNA. (C) <t>VEGF</t> concentration measured by <t>ELISA</t> on GAS protein lysates (∗ p < 0.05; ∗∗∗∗ p < 0.0001, analyzed by one-way ANOVA). (D) CD31 expression quantified by qPCR on total RNA extracted from GAS muscles (∗ p < 0.05, ∗∗∗ p < 0.001; analyzed by one-way ANOVA). (E) CD31 immunostaining of TA muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bars, 50 μm. (F) Distribution of the proportion of fibers as a function of the number of associated blood vessels. (G) Quantification of the mean number of blood vessels per myofiber (∗ p < 0.05, ∗∗∗∗ p < 0.0001; analyzed by one-way ANOVA). (H and I) Proportion of fibers with no associated blood vessels (H) or associated with 5 vessels (I). (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Data regarding blood vessels were obtained from CD31 immunostaining. (J) Quantification of the VEGFR3 expression by qPCR on GAS RNA (∗∗ p < 0.01, analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).
    Vegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+vegf+elisa+kit/pm41760328-115-0-11?v=R%26D+Systems
    Average 96 stars, based on 1 article reviews
    vegf - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    Image Search Results


    Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) mRNA and protein expression levels in different groups.

    Journal: PLOS One

    Article Title: Targeted transferosomal delivery of cetirizine: A new approach to alopecia management

    doi: 10.1371/journal.pone.0347648

    Figure Lengend Snippet: Insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) mRNA and protein expression levels in different groups.

    Article Snippet: IGF-1 and VEGF protein levels in hair bulbs were measured using a Mouse & Rat IGF-I/IGF-1 ELISA Kit (Quantikine; R&D systems, Minneapolis, MN, USA) and a Mouse VEGF ELISA Kit (Quantikine; R&D systems), respectively, according to the manufacturer’s instructions [ ].

    Techniques: Expressing

    TRIM enhances vascularity. ( A , B ) Representative images of TA cross-sections in WT and D2. mdx mice at 14 dpt. Laminin + immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. ( C ) Summary values ( n = 4–5/group) for area occupied by ECs were calculated as: total EC area/number (#) of fibers. ( D ) Summary values ( n = 4–5/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers. Summary values presented for 14 dpt. Angiogenic factors are increased with TRIM. ( E ) VEGF concentration in whole-muscle TA homogenates ( n = 5/group) probed for by ELISA. Summary values are means ± SEM; comparisons made vs. WT and vehicle controls by 2-Way ANOVA, p < 0.05 = significant. Scale bars = 100 μm.

    Journal: Journal of Functional Biomaterials

    Article Title: A Borophosphate Glass Doped with Cobalt Oxide Improves Skeletal Muscle Structure and Function in Myopathic Mice

    doi: 10.3390/jfb17030155

    Figure Lengend Snippet: TRIM enhances vascularity. ( A , B ) Representative images of TA cross-sections in WT and D2. mdx mice at 14 dpt. Laminin + immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. ( C ) Summary values ( n = 4–5/group) for area occupied by ECs were calculated as: total EC area/number (#) of fibers. ( D ) Summary values ( n = 4–5/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers. Summary values presented for 14 dpt. Angiogenic factors are increased with TRIM. ( E ) VEGF concentration in whole-muscle TA homogenates ( n = 5/group) probed for by ELISA. Summary values are means ± SEM; comparisons made vs. WT and vehicle controls by 2-Way ANOVA, p < 0.05 = significant. Scale bars = 100 μm.

    Article Snippet: Samples of muscle supernatant (50 μL; referred to above) were analyzed to determine VEGFA protein concentration using a Quantikine ELISA (Cat.# MMV00, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions.

    Techniques: Immunostaining, Staining, Concentration Assay, Enzyme-linked Immunosorbent Assay

    TRIM enhances vascularity. Representative images of TA cross-sections in D2. mdx Saline (Top) and D2. mdx TRIM (Bottom) mice. ( A ) A 70 dpt and ( E ) 140 dpt. Laminin+ immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. Summary values ( n = 7–8/group) for area occupied by ECs were calculated as: total EC area/number (#) of myofibers. Summary values presented for ( B ) 70 dpt and ( F ) 140 dpt. Summary values ( n = 7–8/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers, presented for ( C ) 70 dpt and ( G ) 140 dpt. Angiogenic factors are increased with TRIM. VEGF concentration in whole muscle TA homogenates probed for by ELISA at ( D ) 70 dpt and ( H ) 140 dpt. ( n = 7–8/group); summary values are means ± SEM. Comparisons made vs. vehicle controls by two-tailed Student’s t -test; p < 0.05 = significant. Scale bars = 100 μm.

    Journal: Journal of Functional Biomaterials

    Article Title: A Borophosphate Glass Doped with Cobalt Oxide Improves Skeletal Muscle Structure and Function in Myopathic Mice

    doi: 10.3390/jfb17030155

    Figure Lengend Snippet: TRIM enhances vascularity. Representative images of TA cross-sections in D2. mdx Saline (Top) and D2. mdx TRIM (Bottom) mice. ( A ) A 70 dpt and ( E ) 140 dpt. Laminin+ immunostaining (white) identified basal laminae surrounding myofibers; CD31 + immunostaining (green) identifies endothelial cells as a measure of vascularity. Laminin intensity in the merged images was reduced to enhance visualization of CD31 + staining. Yellow arrows identify CD31 + staining in merged image. Summary values ( n = 7–8/group) for area occupied by ECs were calculated as: total EC area/number (#) of myofibers. Summary values presented for ( B ) 70 dpt and ( F ) 140 dpt. Summary values ( n = 7–8/group) for EC-to-myofiber ratio were calculated as: # of EC puncta/# of myofibers, presented for ( C ) 70 dpt and ( G ) 140 dpt. Angiogenic factors are increased with TRIM. VEGF concentration in whole muscle TA homogenates probed for by ELISA at ( D ) 70 dpt and ( H ) 140 dpt. ( n = 7–8/group); summary values are means ± SEM. Comparisons made vs. vehicle controls by two-tailed Student’s t -test; p < 0.05 = significant. Scale bars = 100 μm.

    Article Snippet: Samples of muscle supernatant (50 μL; referred to above) were analyzed to determine VEGFA protein concentration using a Quantikine ELISA (Cat.# MMV00, R&D Systems, Minneapolis, MN, USA) according to the manufacturer’s instructions.

    Techniques: Saline, Immunostaining, Staining, Concentration Assay, Enzyme-linked Immunosorbent Assay, Two Tailed Test

    Angiogenesis improvement after mLVRF systemic injections (A) Timeline of the injection protocol. Groups of 7- to 10-week-old male mdx mice were injected intravenously with a single dose AAV9 encoding the mLVRF isoform or an AAV9 scramble as control (3E+13 vg/kg) ( n = 4–5 mice per group). Four weeks after this pre-treatment, mice were injected intravenously with ASO (50 mg/kg/week) or PBS during 12 weeks. Age-matched C57BL/10 wild-type mice were used as controls (WT). One week after the last injection, tissues were collected as described in the section. (B) Quantification of the expression of mLVRF performed by qPCR on gastrocnemius (GAS) total RNA. (C) VEGF concentration measured by ELISA on GAS protein lysates (∗ p < 0.05; ∗∗∗∗ p < 0.0001, analyzed by one-way ANOVA). (D) CD31 expression quantified by qPCR on total RNA extracted from GAS muscles (∗ p < 0.05, ∗∗∗ p < 0.001; analyzed by one-way ANOVA). (E) CD31 immunostaining of TA muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bars, 50 μm. (F) Distribution of the proportion of fibers as a function of the number of associated blood vessels. (G) Quantification of the mean number of blood vessels per myofiber (∗ p < 0.05, ∗∗∗∗ p < 0.0001; analyzed by one-way ANOVA). (H and I) Proportion of fibers with no associated blood vessels (H) or associated with 5 vessels (I). (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Data regarding blood vessels were obtained from CD31 immunostaining. (J) Quantification of the VEGFR3 expression by qPCR on GAS RNA (∗∗ p < 0.01, analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Improving angiogenesis ameliorates the efficacy of ASO-based exon skipping for the treatment of Duchenne muscular dystrophy

    doi: 10.1016/j.omtn.2026.102834

    Figure Lengend Snippet: Angiogenesis improvement after mLVRF systemic injections (A) Timeline of the injection protocol. Groups of 7- to 10-week-old male mdx mice were injected intravenously with a single dose AAV9 encoding the mLVRF isoform or an AAV9 scramble as control (3E+13 vg/kg) ( n = 4–5 mice per group). Four weeks after this pre-treatment, mice were injected intravenously with ASO (50 mg/kg/week) or PBS during 12 weeks. Age-matched C57BL/10 wild-type mice were used as controls (WT). One week after the last injection, tissues were collected as described in the section. (B) Quantification of the expression of mLVRF performed by qPCR on gastrocnemius (GAS) total RNA. (C) VEGF concentration measured by ELISA on GAS protein lysates (∗ p < 0.05; ∗∗∗∗ p < 0.0001, analyzed by one-way ANOVA). (D) CD31 expression quantified by qPCR on total RNA extracted from GAS muscles (∗ p < 0.05, ∗∗∗ p < 0.001; analyzed by one-way ANOVA). (E) CD31 immunostaining of TA muscles from WT and scramble-, mLVRF-, ASO-, and mLVRF+ASO-treated mice. Scale bars, 50 μm. (F) Distribution of the proportion of fibers as a function of the number of associated blood vessels. (G) Quantification of the mean number of blood vessels per myofiber (∗ p < 0.05, ∗∗∗∗ p < 0.0001; analyzed by one-way ANOVA). (H and I) Proportion of fibers with no associated blood vessels (H) or associated with 5 vessels (I). (∗ p < 0.05, ∗∗ p < 0.01; analyzed by one-way ANOVA). Data regarding blood vessels were obtained from CD31 immunostaining. (J) Quantification of the VEGFR3 expression by qPCR on GAS RNA (∗∗ p < 0.01, analyzed by one-way ANOVA). Results are expressed as the mean ± SEM ( n = 4–5 per group).

    Article Snippet: Tissue VEGF protein levels were quantified using the Quantikine Mouse VEGF ELISA kit (MMV00, R&D Systems, Minneapolis, MN, USA), according to the manufacturer’s instructions.

    Techniques: Injection, Control, Expressing, Concentration Assay, Enzyme-linked Immunosorbent Assay, Muscles, Immunostaining